GANX
Gain Therapeutics
$1.71
−$0.01 (−0.58%)Sep 10, 2026
Key metrics
The numbers that frame GANX today
- Market cap
- $74.63M
- P/E (TTM)
- -3.7
- EV / FCF
- -3.3
- ROIC
- 1,956.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.53
- 52wk High
- $4.34
Growth
Revenue and earnings trend for GANX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about GANX
Is Gain Therapeutics a good buy?
No. Gain Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Gain Therapeutics is selling at a very high price.
What is the market capitalization of GANX?
Gain Therapeutics's market capitalization is $74.63M.
What is the P/E ratio for GANX stock?
Gain Therapeutics's current P/E ratio is -3.7.
What is the 52-week high for GANX stock?
The 52-week high for Gain Therapeutics is $4.34. The current close of $1.71 is 60.6% below that high.
What is the 52-week low for GANX stock?
The 52-week low for Gain Therapeutics is $1.53. The current close of $1.71 is 11.8% above that low.
Does GANX stock pay dividends?
Gain Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for GANX?
Gain Therapeutics's Debt / Equity ratio is 0.05.